Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee hears testimony on bill to extend Medicaid coverage for biomarker tests
Summary
Senate hearing on SB606 focused on an amendment limiting biomarker testing coverage to Medicaid recipients so the state can collect data on costs and outcomes; DHHS described federal medical-necessity standards and provided a fiscal estimate, while patient advocates urged quicker action to improve early diagnosis.
Concord — Lawmakers heard bipartisan testimony on Senate Bill 606, which would expand access to biomarker testing for Medicaid recipients to support precision medicine and early diagnosis.
Senator Regina Bartzell, prime sponsor, said the proposed amendment narrows the bill to Medicaid only so the state can “collect data to review the impact and potential savings on early treatment of patients.” She told the committee the change aims to avoid immediate rate impacts on commercial insurance while allowing New Hampshire to measure outcomes.
Jonathan Ballard, chief medical officer at the New Hampshire Department of…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
